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Evaluation of the Ehrlich-Ziehl-Neelsen (EZN) and
Amplified Mycobacterium tuberculosis Direct Test
According to the BACTEC Method in Respiratory and
Nonrespiratory Samples*
Aim: Tuberculosis remains a significant and threatening disease, particularly in developing countries.
Mycobacterium tuberculosis should be detected and identified as soon as possible to ensure the prevention of
the spread of the disease. For this purpose, use of fast and reliable laboratory diagnostic methods with high
sensitivity and specificity was initiated in recent years.
Materials and Methods: In this study, 107 respiratory and 198 nonrespiratory (305 in total) samples
submitted to Dicle University Faculty of Medicine Clinical Microbiology Laboratory were examined using the
Ehrlich-Ziehl-Neelsen (EZN), BACTEC 460 TB (Becton and Dickinson Diagnostic Instrument System, Towson,
MD), and MTD (Amplified Mycobacterium tuberculosis Direct Test, Gen-Probe, USA) methods.
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Results: In respiratory samples, sensitivity of EZN was found as 83.33%, specificity as 95.04%, positive
predictive value as 50%, and negative predictive value as 98.96%, whereas in nonrespiratory samples these
values were 18.18%, 98.39%, 40%, and 95.37%, respectively. In respiratory samples, sensitivity of MTD
was found as 83.33%, specificity as 94.05%, positive predictive value as 45.45%, and negative predictive
value as 98.95%, whereas in nonrespiratory samples these values were 54.54%, 88.23%, 21.42%, and
97.05%, respectively.
Conclusions: In view of the above, the pre-diagnostic EZN test and the MTD method based on nucleic acid
amplification should be applied together with the BACTEC 460 system, which is considered as a gold standard,
and the evaluation should be made accordingly. Furthermore, MTD should not be used as a screening test due
to its high cost, and should rather be preferred in smear-positive samples.
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Solunum ve Solunum D›ﬂ› Örneklerde BACTEC Yöntemine Göre
Ehrlich- Ziehl-Neelsen (EZN) ve Amplified Mycobacterium
Tuberculosis Direct Test Yöntemlerinin De¤erlendirilmesi
Amaç: Tüberküloz özellikle geliﬂmekte olan ülkelerde önemli ve tehdit edici bir hastalık olarak varlı¤ını
sürdürmektedir. Hastalı¤ın yayılımının önlenmesi bakımından Mycobacterium tuberculosis’in tespiti ve
identifikasyonunun mümkün olan en kısa sürede yapılması gerekmektedir. Bu amaçla son yıllarda duyarlılık ve
özgüllü¤ü yüksek, güvenilir, hızlı laboratuvar tanı yöntemleri kullanılmaya ba¤lanmıﬂtır.
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Yöntemler: Bu çalıﬂmada Dicle Üniversitesi Tıp Fakültesi Klinik Mikrobiyoloji Laboratuvarı’na gönderilen 107
respiratuar ve 198 nonrespiratuar olmak üzere toplam 305 örnek Ehrlich- Ziehl-Neelsen (EZN), BACTEC 460
TB (Becton and Dickinson Diagnostik Insturment Sistem, Towson, MD), MTD (Amplified Mycobacterium
tuberculosis Direct Test, Gen-Probe, ABD) yöntemleri ile incelenmiﬂtir.
Bulgular: EZN için respiratuar örneklerde duyarlılık %83.33, özgüllük %95.04, pozitif prediktif de¤er %50,
negatif prediktif de¤er %98.96, nonrespiratuar örneklerde ise bu de¤erler sırasıyla %18.18, %98.39, %40,
%95.37 MTD için respiratuar örneklerde duyarlılık %83.33, özgüllük %94.05, pozitif prediktif de¤er
%45.45, negatif prediktif de¤er %98.95, nonrespiratuar örneklerde ise bu de¤erler sırasıyla %54.54,
%88.23, %21.42, %97.05 olarak bulunmuﬂtur.
Sonuç: Ön tanı testi olan EZN ve nükleik asit amplifikasyon esasına dayanan MTD yöntemlerinin, altın standart
olarak kabul edilen BACTEC TB 460 sistemiyle birlikte çalıﬂılması ve de¤erlendirmelerin buna göre yapılması
gerekmektedir. Ayrıca pahalı olması nedeni ile MTD, tarama testi olarak kullanılmamalı, daha çok smear pozitif
örneklerde kullanılmaları tercih edilmelidir.
Anahtar Sözcükler: Tuberculosis, MTD, BACTEC, EZN
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Introduction

Materials and Methods

Tuberculosis is currently the most widespread and
lethal infectious disease throughout the world, and is
considered a serious public health problem. One-third of
the world’s population is infected with Mycobacterium
tuberculosis. The number of individuals affected by
tuberculosis began to increase again after 1985. The
increase was reported as due to the transmission of the
disease from the homeless, drug and alcohol addicts,
hostages, and individuals infected with human
immunodeficiency virus (HIV) due to difficulty in its
eradication to other communities, including health
employees, as well as to the development of multidrug
resistance in those who receive improper treatment
(1,2).

A total of 107 respiratory samples consisting of 100
(93.4%) sputum and 7 (6.54%) bronchoalveolar lavage
samples, and 198 nonrespiratory samples consisting of
74 (37.4%) cerebrospinal fluid, 34 (17.2%) urine, 17
(8.6%) gastric fluid, 29 (14.6%) pleural fluid, 26
(13.1%) acid fluid, 10 (5.1%) abscess, 4 (2%)
pericardial fluid, 3 (1.5%) joint fluid, and 1 (0.5%)
nephrostomy samples collected from patients prediagnosed with tuberculosis and sent to the Clinical
Microbiology Laboratory of Dicle University Faculty of
Medicine were examined in the study. Following
decontamination (with NaOH) and homogenization of the
clinical samples, preparations of samples were stained
with the EZN method and examined microscopically.
Cultures were started following addition of PANTA into
the Middlebrook 7 TH 12 (BACTEC 12B) medium. The
level of CO, which is formed as a result of C-labeled
palmitic acid utilization by mycobacteria, was measured
routinely 2-3 times a week in the BACTEC 460 TB
(Becton and Dickinson Diagnostic Instrument System,
Towson, MD) instrument. These measured values
displayed the growth index (GI). Distinction of the M.
tuberculosis complex and mycobacteria other than
tuberculosis was made by NAP test at a GI of 50-100.
Mycobacterial target nucleic acid (16S rRNA) was
obtained by MTD (Gen-Probe, USA); sonication method
was amplified isothermally by TMA method. Amplicons
were combined with acridinium ester-labeled DNA probes
to form stable RNA-DNA hybrids in the HPA stage.
Luminometric measurements of the labeled RNA-DNA
hybrids were performed in relative light units (RLU).

The most important phase in tuberculosis control is
early and correct diagnosis of active cases. Although
clinical findings and traditional diagnostic methods
(tuberculosis skin test, chest radiography, etc.) may be
illuminating, definitive diagnosis is possible through the
isolation of the bacillus from the appropriate clinical
samples. However, a long period of 2 to 8 weeks is
required to isolate M. tuberculosis. Therefore,
demonstration of acid-resistant bacilli in directly stained
preparations is important in pre-diagnosis (3).
Identification of mycobacteria and performance of
sensitivity tests in as fast as 1 to 2 weeks is possible by
using the BACTEC 460 TB system, which is recognized as
the gold standard from among the radiometric methods
by the National Committee for Clinical Laboratory
Standards (NCCLS) (4).
The Amplified M. tuberculosis Direct Test (MTD–GenProbe, USA), which is among the tests based on nucleic
acid amplification, is one of the Food and Drug
Administration (FDA)-approved systems aimed at target
amplification. In this system, Transcription-Mediated
Amplification (TMA) and Gene Probe Hybridization
Protection Assay (HPA) are combined and amplification
and screening take place in two consecutive phases (5).
In this study, respiratory and nonrespiratory samples
pre-diagnosed as tuberculosis sent to the Dicle University
Clinical Microbiology Laboratory were examined using the
conventional Ehrlich-Ziehl-Neelsen (EZN) staining, the
molecular diagnostic MTD, and the BACTEC 460 TB
system, which is referred to as the gold standard. The
results obtained are compared based on the BACTEC 460
TB.
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In the statistical analysis, sensitivity, specificity, and
positive and negative predictive values for EZN and MTD
methods were calculated with methodological
investigations, with BACTEC radiometric culture system
taken as a reference (6).

Results
The results of our study revealed 5.60% positivity in
the respiratory samples and 5.55% in the nonrespiratory
samples by BACTEC 460 TB system analysis. EZN
staining method revealed rates of positivity of 9.34% and
2.52%, respectively, while these rates were found as
10.2% and 14.14%, respectively, with the MTD system.
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The results for the EZN staining method and the
BACTEC 460 TB system used for the laboratory diagnosis
of the respiratory and non-respiratory samples are given
in Table 1.

examination, culturing, and identification, followed by
susceptibility tests to primary anti-tuberculosis drugs.
Various staining methods are applied to the preparations
of clinical samples for microscopic examination (1,2).

The results obtained by MTD method in the
respiratory and non-respiratory samples are presented in
Table 2 along with BACTEC 460 TB system results.

The most widely used staining method is EZN, which
is also the first process we perform in our laboratory for
detection of tuberculosis bacilli in the samples. Ease of
application, quickness, and cost effectiveness are the
advantages of the microscopic examination. Nonetheless,
the bacilli can only be detected in direct microscopic
examination if there are 5000-10000 bacilli per milliliter
of the sample, and various studies have revealed that acid
resistance staining was positive in only 50-80% of the
untreated pulmonary tuberculosis patients (7).

Discussion
In spite of the developments in diagnosis and
treatment, tuberculosis is still a globally widespread
infection today, especially in developing countries, due to
the increase in immune system suppressing infections and
malignancies, and multidrug resistance. The treatment
rate is a significant issue in tuberculosis, and diagnosis has
to be made before initiation of the treatment. The
routinely required processes for the laboratory diagnosis
of tuberculosis were defined in three stages by the World
Health Organization (WHO): direct microscopic

In this study, the sensitivity, specificity, and positive
and negative predictive values of the EZN staining method
used in microscopic diagnosis were detected as 83.33%,
95.04%, 50%, and 98.96%, respectively, compared to
the BACTEC 460 TB system, which is considered as the
gold standard. Piersimoni et al. (8), in their study on

Table 1. Results obtained by BACTEC and EZN methods in the respiratory samples.

EZN

BACTEC
Positive

Negative

Positive

2

3

Negative

9

184

Nonrespiratory (n=198)

Respiratory (n=107)
Positive

5

5

Negative

1

96

Sensitivity

Specificity

PPV

NPV

(%)

(%)

(%)

(%)

%18.18

%98.39

%40

%95.33

%83.33

%95.04

%50

%98.96

EZN: Ehrlich-Ziehl-Neelsen. PPV: Positive predictive value. NPV: Negative predictive value.

Table 2. Results obtained by BACTEC and MTD methods in the non-respiratory samples.
MTD

BACTEC
Positive

Negative

Positive

6

22

Negative

5

165

Positive

5

6

Negative

1

95

Nonrespiratory (n=198)

Respiratory (n=107)

Sensitivity

Specificity

PPV

NPV

(%)

(%)

(%)

(%)

%54.54

%88.23

%21.42

%97.05

%83.33

%94.05

%45.45

%98.95

MTD: Amplified M. tuberculosis direct test. PPV: Positive predictive value. NPV: Negative predictive value.
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respiratory samples, reported sensitivity of the method as
77%, whereas they declared its specificity and positive
and negative predictive values to be 100%, 100%, and
95%, respectively. High values reported in the study by
Presimoni et al. (8) are due to the patient group selected
by the investigators including individuals with definite
diagnosis of tuberculosis.
In this study, these values were found as 18.18%,
98.39%, 40%, and 95.37%, respectively, for the
nonrespiratory samples. Pınar et al. (12) found a higher
degree of sensitivity in the clinical samples with values of
48.8%, 92.9%, 27.2%, and 97.1%, without distinction
between the respiratory and nonrespiratory samples.
Techniques based on amplification were developed for
tuberculosis disease, to quicken the isolation of the
bacillus and to increase sensitivity. In this study,
sensitivity of the MTD method was found to be 83.33%
in the respiratory samples and 54.54% in the
nonrespiratory samples. The sensitivity value for MTD
(detected as 83.33% in respiratory samples) is in
accordance with the values found by Pfyffer et al. (9)
(86.6%) and Gamboa et al. (10) (86.8%). However,
Vlaspolder et al. (11) (98.4%) and Piersimoni et al. (8)
(95%) detected high values, while a low sensitivity was
reported by Pınar et al. (12) (67.6%). The high
specificity detected for MTD in the respiratory samples in
our study (94.05%) is in accordance with the values
detected by other investigators (between 96.4% and
100%). Sensitivity and specificity values detected in the
nonrespiratory samples in our study were 54.54% and
88.23%, respectively. These values were reported by
Pfyffer et al. (9) as 93.1% and 97.7%, by Vlaspolder et
al. (11) as 100% and 95%, by Woods et al. (13) as
87.5% and 100%, and by Gamboa et al. (10) as 93.1%
and 97.7%, respectively. The different results reported
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in the literature by Pfyffer et al. (9) for MTD sensitivity
were related with different technicians performing the
tests and with the large variety of samples tested.
While MTD is a sensitive, easy to apply and quick test,
it requires a good quality procedure and a controlled
study. Various factors have been related to the falsepositive and false-negative results in the MTD method in
the literature. For instance, Vlaspolder et al. (11) stated
that excessive contamination with blood accounted for
the false-positive results obtained in respiratory samples.
The same study stated that MTD-positive and culturenegative results were common in patients receiving
treatment. MTD was observed to turn negative during
the therapy. It was claimed that MTD could be used for
the follow-up of the therapy. Some studies recommend
the use of the MTD test in smear-negative cases, to
provide early initiation of the specific therapy (14). Other
investigators suggest that MTD should only be preferred
in smear-positive clinical samples, due to higher
sensitivity and higher cost in smear-positive samples
(5,15).
As the MTD method is applied according to certain
protocols and is a standardized method, the likelihood of
application errors is quite low. A low positive predictive
value and a high negative predictive value suggest a
careful evaluation of the positive results obtained by
MTD, and a higher reliability of the negative results (12).
In conclusion, the pre-diagnostic EZN test and the
MTD method based on nucleic acid amplification should
be applied together with the BACTEC 460 system, which
is considered as a gold standard, and the evaluation
should be made accordingly. Furthermore, MTD should
not be used as a screening test due to the high cost, and
should rather be preferred in smear-positive samples.
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